BMRA News and Press, Biomerica Inc. From 11/08/23

Biomerica remains on track for inFoods ® IBS national rollout during calendar 2024, and expects strong product revenue growth during national rollout Veteran Vice President of Sales and National Accounts hired along with first set of regional sales representatives IRVINE,...

2023-10-30 08:34:25 ET Miromatrix Medical ( MIRO ) +225% to buy Miromatrix Medical for $3.25 per share, MIRO jumps 225%. TD Holdings  ( BYU ) +63% . Conduit Pharmaceuticals ( CDT ) +56% . VYNE Therapeutics Inc ( VYNE ) +47% jumps 52% on posit...

Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate strategy is expected to enable it to achieve profitability GAAP gross margin...

Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate strategy is expected to enable it to achieve profitability GAAP gross margin...

Fast Retailing Co. Ltd. ADR (FRCOY) is expected to report for Q4 2023 Walgreens Boots Alliance Inc. (WBA) is expected to report $0.68 for Q4 2023 Rite Aid Corporation (RAD) is expected to report $-1.35 for Q2 2024 Greystone Logistics Inc (GLGI) is expected to report for Q2 2024 Se...

Biomerica Inc. (BMRA) is expected to report for Q2 2024

2023-09-28 13:12:05 ET More on Biomerica Biomerica jumps as CVS Health to launch cancer screening test Financial information for Biomerica For further details see: Biomerica files to sell shares with total gross proceeds of up to $20M

IRVINE, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that the Dubai government has officially approved insurance reimbursement for the EZ Detect colorectal disease at-home screening test, which is designed to detect an ear...

Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian Bioscience As CEO Kenny managed the sale of Meridian Biosciences in an all-cash transaction val...

Revenues excluding Covid test sales increased 15% for fiscal 2023 vs fiscal 2022 Successfully completed inFoods ® IBS pilot program with one of the largest Gastrointestinal physician groups in the US inFoods IBS completes pre-launch phase; Veteran VP of sales ...